- Published at
- by gurufocus.com
neutral
neutral
RBC Capital Adjusts Price Target for Genmab (GMAB) Following Q1 Results | GMAB Stock News
RBC Capital has revised the price target for Genmab (GMAB), reducing it from DKK 2,300 to DKK 2,000, while maintaining an Outperform rating. This adjustment fol